Abstract:The development of therapeutic interventions for diseases necessitates a crucial step known as drug screening, wherein potential substances with medicinal properties are rigorously evaluated. This process has undergone a transformative evolution, driven by the imperative need for more efficient, rapid, and high-throughput screening platforms. Among these, microfluidic systems have emerged as the epitome of efficiency, enabling the screening of drug candidates with unprecedented speed and minimal sample consumption. This review paper explores the cutting-edge landscape of microfluidic-based drug screening platforms, with a specific emphasis on two pioneering approaches: organ-on-a-chip and C. elegans-based chips. Organ-on-a-chip technology harnesses human-derived cells to recreate the physiological functions of human organs, offering an invaluable tool for assessing drug efficacy and toxicity. In parallel, C. elegans-based chips, boasting up to 60% genetic homology with humans and a remarkable affinity for microfluidic systems, have proven to be robust models for drug screening. Our comprehensive review endeavors to provide readers with a profound understanding of the fundamental principles, advantages, and challenges associated with these innovative drug screening platforms. We delve into the latest breakthroughs and practical applications in this burgeoning field, illuminating the pivotal role these platforms play in expediting drug discovery and development. Furthermore, we engage in a forward-looking discussion to delineate the future directions and untapped potential inherent in these transformative technologies. Through this review, we aim to contribute to the collective knowledge base in the realm of drug screening, providing valuable insights to researchers, clinicians, and stakeholders alike. We invite readers to embark on a journey into the realm of microfluidic-based drug screening platforms, fostering a deeper appreciation for their significance and promising avenues yet to be explored.

State-of-the-art in high throughput organ-on-chip for biotechnology and pharmaceuticals

Emerging Trends in Organ-on-a-chip Systems for Drug Screening

Revolutionizing Drug Discovery: The Impact of Distinct Designs and Biosensor Integration in Microfluidics-Based Organ-on-a-Chip Technology

Organ-On-A-Chip: An Emerging Research Platform

Organ-on-a-chip: A new tool for in vitro research

Engineering Organoids-on-chips for Drug Testing and Evaluation

Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery

Organ-on-a-chip: recent breakthroughs and future prospects

Organ-on-chip technology: Opportunities and challenges

Organ-on-a-chip meets artificial intelligence in drug evaluation

The Synergy between Deep Learning and Organs-on-Chips for High-Throughput Drug Screening: A Review

Organs-on-chips at the frontiers of drug discovery

A Comprehensive Review of Organ-on-a-Chip Technology and Its Applications

Organ-On-a-Chip devices: Technology Progress and Challenges

Trends in Organ-on-a-chip for Pharmacological Analysis

Advances in Human Organs-on-Chips and Applications for Drug Screening and Personalized Medicine

Bridging the academia-to-industry gap: organ-on-a-chip platforms for safety and toxicology assessment

A Comprehensive Review of Organ-on-Chip/Body-on-Chip Systems: Engineering, Applications, and Potential Impact on Drug Development and Administration

Progress in the Application of Organoids-On-A-Chip in Diseases

Microfluidics in High-Throughput Drug Screening: Organ-on-a-Chip and C. elegans-Based Innovations

Organ/body-on-a-chip based on microfluidic technology for drug discovery